High cut-off dialysis as a salvage therapy option in high-dose methotrexate chemotherapy?

Annals of Hematology

Volumn 93, Issue 6, 2014, Pages 1053-1055

  Bertram, Anna ^a   Ivanyi, Philipp ^a   Hafer, Carsten ^a   Matthias, Kathrin ^a   Peest, Dietrich ^a   Ganser, Arnold ^a   Schmidt, Bernhard M W ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ACUTE KIDNEY FAILURE; AGED; ARTIFICIAL KIDNEY; B CELL LYMPHOMA; CANCER PATIENT; CASE REPORT; DIALYSATE; DRUG MEGADOSE; DRUG WITHDRAWAL; HEMODIALYSIS; HUMAN; LETTER; MALE; PATIENT SAFETY; PRIORITY JOURNAL;

ACUTE KIDNEY INJURY; AGED; BRAIN; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; HUMANS; KIDNEY TUBULAR NECROSIS, ACUTE; LEUCOVORIN; LYMPHOMA, B-CELL; MALE; METABOLIC CLEARANCE RATE; METHOTREXATE; RECURRENCE; RENAL DIALYSIS; SALVAGE THERAPY;

EID: 84902262616     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1909-8     Document Type: Letter

References (8)

1. Ackland SP, Schilsky RL (1987) High-dose methotrexate: a critical reappraisal. J Clin Oncol 5:2017-2031 (Pubitemid 18010164)
2. Smeland E, Fuskevag OM, Nymann K, Svendesn JS, Olsen R, Lindal S, Bremnes RM, Aarbakke J (1996) High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model. Cancer Chemother Pharacol 37:415-422 (Pubitemid 26054549)
3. Abelson HT, Fosburg MT, Beardsley GP, Goorin AM, Gorka C, Link M, Link D (1983) Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J Clin Oncol 1:208-216 (Pubitemid 14245668)
4. Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC (2004) High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer 100:2222-2232 (Pubitemid 38580344)
5. Schwartz S, Borner K,Muller K, Martus P, Fischer L, Korfel A, Auton T, Thiel E (2007) Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy. Oncologist 12:1299-1308 (Pubitemid 350232603)
6. Wall SM, Johansen MJ, Molony DA, DuBose TD Jr, Jaffe N, Madden T (1996) Effective clearance of methotrexate using high-flux hemodialysis membranes. Am J Kidney Dis 28:846-854 (Pubitemid 26412080)
7. Schmidt JJ, Hafer C, Clajus C, Hadem J, Beutel G, Schmidt BM, Kielstein JT (2012) New high-cutoff dialyzer allows improved middle molecule clearance without an increase in albumin loss: a clinical crossover comparison in extended dialysis. Blood Purif 34:246 - 252
8. Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M, Roth A, Hertenstein B, von Toll T, Hundsberger T, Mergenthaler HG, Leithauser M, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Plasswilm L, Nagele T, Pietsch T, Bamberg M, Weller M (2010) High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol 11:1036-1047